Interview with the Innovators

Common Questions from NSCLC Patients and Their Caregivers

Video Library

Featuring:

Kammi Fox-Kay, MSN, RN, AOCNS, ONN-CG(T)
Lung Nurse Navigator
Franciscan Health
Crown Point, IA
Cathy Simmons, RN, BSN, ONN-CG(T)
Thoracic Oncology Navigator
Sarah Cannon Cancer Institute
Plano, Texas
Lauren Welch, MSN, NP-C, AOCNP
Nurse Practitioner
Tennessee Oncology
Nashville, TN
Lauren Welch, Kammi Fox-Kay, and Cathy Simmons share their experiences on the most common questions they are asked by their NSCLC patients and their caregivers, including chances for survival, the meaning of NGS, the stage of their cancer, and nutritional advice.

Related Items

Managing Neuropathy That May Accompany ADC Therapy in Breast Cancer
By Tajuana Bradley, MS, FNP-BC; Abbey J. Kaler, MS, APRN, FNP-C
Video Library
How can clinicians monitor and manage neuropathy in patients with breast cancer receiving ADC therapy? In this video, Tajuana Bradley, MS, FNP-BC, and Abbey J. Kaler, MS, APRN, FNP-C, discuss practical approaches to initial and ongoing assessments, concomitant medication, and patient education on symptoms that should be reported promptly.
Managing Hematologic Toxicities With ADC Therapy in Breast Cancer
By Tajuana Bradley, MS, FNP-BC; Abbey J. Kaler, MS, APRN, FNP-C
Video Library
How can clinicians monitor and manage hematologic toxicities in patients with breast cancer receiving ADC therapy? In this video, Tajuana Bradley, MS, FNP-BC, and Abbey J. Kaler, MS, APRN, FNP-C, discuss practical approaches to laboratory monitoring and the assessment and management of neutropenia, thrombocytopenia, and anemia, including toxicity grading, treatment modifications, and patient education on symptoms that should be reported promptly.
Assessing Patient Risk Before ADC Therapy in Breast Cancer
By Tajuana Bradley, MS, FNP-BC; Abbey J. Kaler, MS, APRN, FNP-C
Video Library
How can early identification of patient-specific risk factors help optimize patient outcomes and proactively manage toxicity with ADC therapy? In this video, Tajuana Bradley, DNP, FNP-BC, AOCNP, and Abbey Kaler, PA-C, discuss approaches to evaluating baseline risk factors, identifying patients who may be at increased risk for key ADC-related toxicities, and implementing monitoring, multidisciplinary care, and patient education strategies at treatment initiation.
Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country